BWM
SPPI

Baystate Wealth Management’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Baystate Wealth Management’s Portfolio SPPI Stock Details SPPI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-11
Closed – – 789
2020
Q3 		$0 Buy
+11
New +$42 ﹤0.01% 765

Other funds holding SPPI

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Baystate Wealth Management's SPPI Position: Q4 2020 in Review

Baystate Wealth Management sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q4 2020, closing a stake of 11 shares.

Baystate Wealth Management first reported a position in SPPI in Q3 2020 and held it in 1 quarter. The position peaked at $0 in Q3 2020. 161 funds tracked by Wall St. Rank hold SPPI as of Q4 2020.

  • Baystate Wealth Management reported no remaining Spectrum Pharmaceuticals Inc position as of Q4 2020 after selling out during the quarter.
  • Baystate Wealth Management sold 11 Spectrum Pharmaceuticals Inc shares in Q4 2020.
  • Baystate Wealth Management first reported a position in Spectrum Pharmaceuticals Inc in Q3 2020 and held it in 1 quarter.
  • Baystate Wealth Management's Spectrum Pharmaceuticals Inc position peaked at $0 in Q3 2020.
  • 161 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q4 2020.

Based on Baystate Wealth Management's 13F filing for Q4 2020, filed 15 Jan 2021.